Rani Therapeutics Holdings Growth Metrics (2020-2026) | RANI

Growth Metrics Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)
0.54M0.09M0.65M
EBITDA Margin Growth (5y) (Quarter)
0.18M0.02M
EBITDA Margin (QoQ) (Quarter)
0.04M-0.55M0.01M
EBIT Margin Growth (1y) (Quarter)
0.54M0.09M0.65M
EBIT Margin Growth (5y) (Quarter)
0.18M0.02M
EBIT Margin (QoQ) (Quarter)
0.04M-0.55M0.01M
EBT Margin Growth (1y) (Quarter)
0.42M0.09M0.68M
EBT Margin Growth (5y) (Quarter)
0.21M0.01M
EBT Margin (QoQ) (Quarter)
0.05M-0.59M-0.00M
Enterprise Value Growth (1y) (Quarter)
-775.62%40.74%173.35%134.80%-104.07%-79.25%-67.50%-28.50%107.60%-97.81%-110.89%-113.19%-133.68%-4,870.77%-666.76%-409.06%-347.41%79.80%
Enterprise Value Growth (3y) (Quarter)
59.89%27.89%70.39%67.98%62.62%-30.39%-31.45%-35.36%51.44%-30.27%
Enterprise Value Growth (5y) (Quarter)
-11.75%32.66%
Enterprise Value (QoQ) (Quarter)
28.73%12.36%232.25%-11.21%-66.18%-613.89%113.45%39.05%-25.59%-45.40%-96.13%-791.92%9.84%-39.40%-448.61%-11.21%40.14%-22.51%75.23%
FCF Margin Growth (1y) (Quarter)
0.09M0.44M
FCF Margin Growth (5y) (Quarter)
0.36M0.02M
FCF Margin (QoQ) (Quarter)
0.02M-0.39M-0.04M
Interest Coverage Ratio Growth (1y) (Quarter)
98.16%94.48%186.13%91.22%52.79%-1,068.49%-162.99%-463.72%2.07%52.34%91.46%20.74%36.71%86.95%-237.00%-17.46%-21.62%14.10%-34.74%73.03%
Interest Coverage Ratio Growth (3y) (Quarter)
79.60%32.53%64.09%26.80%33.62%10.09%-29.69%-73.78%8.99%62.33%27.08%36.91%
Interest Coverage Ratio Growth (5y) (Quarter)
63.44%49.02%26.79%34.10%
Interest Coverage Ratio (QoQ) (Quarter)
-12.53%92.17%3,113.24%-103.31%-505.06%-93.85%-62.44%70.41%-5.11%5.66%70.90%-174.65%16.08%80.54%-651.39%4.27%13.11%86.26%-1,078.58%80.84%
Net Margin Growth (1y) (Quarter)
0.42M0.09M0.68M
Net Margin Growth (5y) (Quarter)
0.22M0.01M
Net Margin (QoQ) (Quarter)
0.05M-0.59M-0.00M
Operating Margin Growth (1y) (Quarter)
0.54M0.09M0.65M
Operating Margin Growth (5y) (Quarter)
0.18M0.02M
Operating Margin (QoQ) (Quarter)
0.04M-0.55M0.01M
Return on Assets Growth (1y) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M-1.000.00M0.00M0.00M-1.00-2.00-2.000.00M1.00
Return on Assets Growth (3y) (Quarter)
-1.00-1.00-1.00-2.00-3.00-1.000.00M
Return on Assets (QoQ) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-1.00-1.003.001.00
Return on Capital Employed Growth (1y) (Quarter)
-0.00M-0.00M-0.00M-0.00M-0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.04M4.44M0.10M0.01M0.04M
Return on Capital Employed Growth (3y) (Quarter)
-0.02M-0.02M-0.04M4.43M0.09M-0.01M-0.00M
Return on Capital Employed (QoQ) (Quarter)
205.00-0.00M-0.00M786.00-155.00-675.00-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.02M4.47M-4.34M-0.10M0.01M
Return on Invested Capital Growth (1y) (Quarter)
-19.00-116.00-209.00-953.0017.00203.00
Return on Invested Capital (QoQ) (Quarter)
-2.00-2.00-2.00-14.00-99.00-94.00871.0092.00
Return on Sales Growth (1y) (Quarter)
42.0011.008.00-34.009.0068.00
Return on Sales Growth (3y) (Quarter)
4.00-12.00
Return on Sales Growth (5y) (Quarter)
-3.00-16.0022.001.00
Return on Sales (QoQ) (Quarter)
5.00-13.00-4.00-59.0026.005.0037.000.00M